Shonali Midha
Hematologist and autologous transplant physician at Dana-Farber Cancer Institute with clinical interests in myeloma, early-phase clinical research, bispecifics and digital health; discusses transplant eligibility, melphalan dosing, mobilization and MRD-adapted approaches in this episode.
Best podcasts with Shonali Midha
Ranked by the Snipd community
Mar 12, 2026 • 0sec
Episode 148: Myeloma Series, Pt. 8- Transplant in Multiple Myeloma (2026)
Dr. Amar Kelkar, Dana-Farber transplant physician focused on allogeneic transplant and ethics, and Dr. Shonali Midha, Dana-Farber myeloma specialist and autologous transplant expert, discuss transplant candidacy and pre-transplant testing. They walk through stem cell collection and mobilization, melphalan dosing, MRD-adapted strategies, second transplants, allogeneic roles, and financial/cost-effectiveness considerations.
